Abstract
The mast cell granule provides three distinct sources of mediators: (1) preformed and rapidly released (histamine), (2) secondarily formed and generated by the interaction of primary mediators and nearby cells and tissues (leukotrienes), and (3) granule matrix-derived, which are preformed but remain associated with the granule proteoglycans after discharge (proteases) (Table). The granule matrix and its associated mediators may remain in the tissue for hours until removed through degradation, dissolution, or phagocytosis. The events initiated by the mediators depend on the tissues into which they are released. Mediator discharge clearly initiates the events associated with immediate hypersensitivity; however, late-phase reactions occur in response to granule-derived mediators as well. Several manifestations that may result from the introduction of mast cell-derived products within the gastrointestinal tract are shown in Fig. 5. These include increased vascular permeability and secretion of mucus, effects on cell surface receptors, chemotaxis of various cell types, and smooth muscle contraction. Thus the mast cell, because of its unique anatomic location and mediators, may serve both as an initiator of acute inflammation and a p...Continue Reading
References
Jun 1, 1979·The Journal of Allergy and Clinical Immunology·M Plaut
Apr 1, 1976·The Journal of Clinical Investigation·R E Rocklin
Sep 1, 1976·The Journal of Investigative Dermatology·N A Soter, K F Austen
Sep 1, 1977·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·J Tas, R G Berndsen
Oct 1, 1979·Cellular Immunology·G Mayrhofer
Sep 19, 1979·The Journal of Experimental Medicine·Y KitamuraM Seki
Dec 1, 1979·The Journal of Clinical Investigation·D D MetcalfeK F Austen
Feb 1, 1978·The Journal of Experimental Medicine·J M WeilerK F Austen
Jul 1, 1978·The Journal of Investigative Dermatology·B Uvnäs
Jun 1, 1978·Agents and Actions·K MohriD Weber
Jan 1, 1966·The American Journal of Digestive Diseases·G AstaldiR Airo
May 14, 1981·Nature·Y KitamuraK J Mori
May 1, 1981·Digestive Diseases and Sciences·K M WalusE D Jacobson
May 1, 1980·The Journal of Cell Biology·J P CaulfieldK F Austen
May 1, 1980·The Journal of Investigative Dermatology·H H NewballL M Lichtenstein
Aug 1, 1981·Journal of Clinical Pathology·S StrobelA Ferguson
Sep 1, 1983·International Journal of Dermatology·R F Lemanske, M A Kaliner
Feb 1, 1980·The Journal of Clinical Investigation·J A DenburgJ Bienenstock
Jan 1, 1982·International Archives of Allergy and Applied Immunology·E J RuitenbergH M Ruitenberg
Nov 1, 1980·Human Pathology·A M DvorakG R Dickersin
Apr 1, 1963·Gastroenterology·H T NORRISL S GOTTLIEB
Aug 1, 1964·British Journal of Pharmacology and Chemotherapy·A BUCKNELL, B WHITNEY
Citations
Jan 1, 1984·Acta Neuropathologica·K L Ho
Apr 1, 1986·Agents and Actions·F DielS Hosenfeld
Apr 1, 1989·Agents and Actions·H NolteP O Schiøtz
Feb 1, 1986·Regulatory Peptides·F Diel, S Szabo
Nov 1, 1986·Pediatric Dermatology·D H Stein
Jul 1, 1990·Gut·H NolteB Windelborg
Feb 18, 2016·Mucosal Immunology·V S PellyM S Wilson
Oct 1, 1990·The American Journal of Medicine·A J BridgesA A Diaz-Arias
Nov 1, 1989·Allergy·H NolteP O Schiøtz
Nov 1, 1989·Allergy·H NolteP Stahl Skov
Nov 19, 2002·Revista do Hospital das Clínicas·Alexander Roberto Precioso, Renata Suman Mascaretti Proenca
Jan 1, 1995·European Journal of Immunology·S KraussG Riethmüller
Jan 1, 1986·Critical Reviews in Toxicology·S L Taylor
May 1, 1987·Gut·J O GebbersD P Jewell
Jul 1, 1987·International Journal of Dermatology·S A Melman
Feb 1, 1986·Infection and Immunity·R B SartorJ H Schwab